Design Therapeutics, Inc. DSGN Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s short-term investments?
- Design Therapeutics, Inc. (DSGN) reported short-term investments of $210.05M in Q1 2026.
- How has Design Therapeutics, Inc.'s short-term investments changed year-over-year?
- Design Therapeutics, Inc.'s short-term investments decreased by 2.8% year-over-year, from $216.01M to $210.05M.
- What is the long-term trend for Design Therapeutics, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s short-term investments has grown at a 43.2% compound annual growth rate (CAGR), from $33.71M to $202.99M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.